Mark Identification

POINT: PERFORMANCE OF HSP 90 INHIBITOR AS INITIAL THERAPY IN MULTIPLE MYELOMA: TANESPIMYCIN

Serial Number

77795564

Filing Date

Aug 3, 2009

Trademark by

Classification Information

Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use